

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.91302153 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 4.91302153 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.91302153 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.91302153 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.91302153 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.91302153 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 4.81158943 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.76577160 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.74022349 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.71929749 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.71929749 |
| 12 | response to peptidoglycan (GO:0032494) | 4.53384657 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.39078758 |
| 14 | cellular response to type I interferon (GO:0071357) | 4.36753509 |
| 15 | type I interferon signaling pathway (GO:0060337) | 4.36753509 |
| 16 | response to type I interferon (GO:0034340) | 4.32156961 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.31370277 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 4.30450907 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 4.26355492 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.24577027 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.19641421 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07241630 |
| 23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.04451972 |
| 24 | detection of other organism (GO:0098543) | 4.02993314 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.02771690 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 3.83967456 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.76739588 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.74729416 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.73038428 |
| 30 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.67944115 |
| 31 | detection of bacterium (GO:0016045) | 3.64342821 |
| 32 | microglial cell activation (GO:0001774) | 3.63382294 |
| 33 | T-helper 1 type immune response (GO:0042088) | 3.58791445 |
| 34 | positive regulation of interferon-alpha production (GO:0032727) | 3.58148326 |
| 35 | defense response to protozoan (GO:0042832) | 3.54086399 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.54085632 |
| 37 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.52035210 |
| 38 | regulation of vitamin metabolic process (GO:0030656) | 3.49994363 |
| 39 | macrophage activation (GO:0042116) | 3.45311708 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42265705 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 3.37835131 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.35690255 |
| 43 | response to host immune response (GO:0052572) | 3.35690255 |
| 44 | germinal center formation (GO:0002467) | 3.35542987 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.35252319 |
| 46 | neutrophil activation (GO:0042119) | 3.33861337 |
| 47 | granulocyte activation (GO:0036230) | 3.33374767 |
| 48 | B cell mediated immunity (GO:0019724) | 3.28451487 |
| 49 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24849056 |
| 50 | response to protozoan (GO:0001562) | 3.21336334 |
| 51 | leukocyte aggregation (GO:0070486) | 3.20544372 |
| 52 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.19829217 |
| 53 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.17648229 |
| 54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.14044884 |
| 55 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.13201936 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.12939653 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 3.10832597 |
| 58 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.09234663 |
| 59 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.08829508 |
| 60 | interferon-gamma secretion (GO:0072643) | 3.08784871 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.08630980 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05926353 |
| 63 | respiratory burst (GO:0045730) | 3.02966421 |
| 64 | response to host (GO:0075136) | 3.02936365 |
| 65 | response to host defenses (GO:0052200) | 3.02936365 |
| 66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02936365 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02514858 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99587652 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 2.99048851 |
| 70 | cellular response to interferon-gamma (GO:0071346) | 2.98699899 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.98594833 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 2.97390851 |
| 73 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.97080880 |
| 74 | regulation of podosome assembly (GO:0071801) | 2.91478284 |
| 75 | positive regulation of interferon-beta production (GO:0032728) | 2.90965618 |
| 76 | cellular extravasation (GO:0045123) | 2.90330213 |
| 77 | regulation of cellular extravasation (GO:0002691) | 2.90325975 |
| 78 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89698390 |
| 79 | response to interferon-alpha (GO:0035455) | 2.89303804 |
| 80 | regulation of type 2 immune response (GO:0002828) | 2.88602701 |
| 81 | regulation of interleukin-12 production (GO:0032655) | 2.87688282 |
| 82 | dendritic cell chemotaxis (GO:0002407) | 2.87152674 |
| 83 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87152022 |
| 84 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.85826635 |
| 85 | regulation of tolerance induction (GO:0002643) | 2.85449095 |
| 86 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.85197712 |
| 87 | response to interferon-gamma (GO:0034341) | 2.84450754 |
| 88 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.83831914 |
| 89 | myeloid dendritic cell differentiation (GO:0043011) | 2.79632593 |
| 90 | response to muramyl dipeptide (GO:0032495) | 2.79480640 |
| 91 | negative regulation of viral genome replication (GO:0045071) | 2.78177214 |
| 92 | regulation of regulatory T cell differentiation (GO:0045589) | 2.74734737 |
| 93 | neutrophil mediated immunity (GO:0002446) | 2.74060438 |
| 94 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.73338727 |
| 95 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.72935010 |
| 96 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.72129670 |
| 97 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.71748325 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.69945719 |
| 99 | positive regulation of acute inflammatory response (GO:0002675) | 2.67799863 |
| 100 | regulation of mast cell degranulation (GO:0043304) | 2.67434011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.49856066 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.94797160 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.81251614 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.67883241 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.54909635 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.51246399 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28950479 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.24895209 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24351784 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12620774 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01702973 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90830014 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90265928 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66258221 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.55312589 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.40847482 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37407929 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31517457 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.08877787 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06960286 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05300667 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.03108451 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01967575 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.94854267 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93720135 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85299551 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83778586 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82165268 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.75062994 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.74230518 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.68713424 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68508376 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65592715 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63559928 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63119584 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61253545 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59370008 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57939889 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.56624543 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54500240 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.45272658 |
| 42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43854801 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36318388 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34592509 |
| 45 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33158900 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28834601 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28261889 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27650323 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25155624 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25142944 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24729725 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23828130 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23692908 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23657376 |
| 55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20697311 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.20275184 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19764802 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19106971 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16560982 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13703359 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13257938 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13218561 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12523238 |
| 64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.12140705 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11599920 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07110863 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05851543 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04374495 |
| 69 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01325969 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99686348 |
| 71 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99417156 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99381521 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97629010 |
| 74 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97100899 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96539555 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96284999 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95503202 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95438610 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 0.94780033 |
| 80 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94412044 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94135315 |
| 82 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90874491 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90788402 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.90535587 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88901839 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88765245 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88198454 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87928851 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87159605 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86517530 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84740118 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84167301 |
| 93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81486032 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80975265 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79576518 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78469646 |
| 97 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76085223 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74271885 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73851035 |
| 100 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.73473126 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.21853366 |
| 2 | MP0003303_peritoneal_inflammation | 5.10170429 |
| 3 | MP0003436_decreased_susceptibility_to | 3.61649888 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.58426216 |
| 5 | MP0009785_altered_susceptibility_to | 3.43932897 |
| 6 | MP0006082_CNS_inflammation | 3.10171598 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.91601395 |
| 8 | MP0005671_abnormal_response_to | 2.78943109 |
| 9 | MP0005025_abnormal_response_to | 2.76959553 |
| 10 | MP0005387_immune_system_phenotype | 2.73798518 |
| 11 | MP0001790_abnormal_immune_system | 2.73798518 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.72821601 |
| 13 | MP0002419_abnormal_innate_immunity | 2.66745794 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.54362093 |
| 15 | MP0001800_abnormal_humoral_immune | 2.50316526 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.45761072 |
| 17 | MP0002723_abnormal_immune_serum | 2.32455911 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.26299659 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.21020718 |
| 20 | MP0009764_decreased_sensitivity_to | 2.16148466 |
| 21 | MP0000685_abnormal_immune_system | 2.12626567 |
| 22 | MP0004510_myositis | 2.08573537 |
| 23 | MP0005451_abnormal_body_composition | 2.01698458 |
| 24 | MP0001819_abnormal_immune_cell | 2.00769816 |
| 25 | MP0004947_skin_inflammation | 2.00144281 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.99417315 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.93311605 |
| 28 | MP0003075_altered_response_to | 1.87209542 |
| 29 | MP0008004_abnormal_stomach_pH | 1.72667308 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.69295026 |
| 31 | MP0009278_abnormal_bone_marrow | 1.67233084 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.65696113 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.64933739 |
| 34 | MP0005166_decreased_susceptibility_to | 1.63513815 |
| 35 | MP0008469_abnormal_protein_level | 1.62476399 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.57312329 |
| 37 | MP0003866_abnormal_defecation | 1.55782386 |
| 38 | MP0008260_abnormal_autophagy | 1.55592646 |
| 39 | MP0002405_respiratory_system_inflammati | 1.55369522 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.50447940 |
| 41 | MP0000716_abnormal_immune_system | 1.45236455 |
| 42 | MP0005310_abnormal_salivary_gland | 1.42528029 |
| 43 | MP0000343_altered_response_to | 1.36021295 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.35070210 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.34995716 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.34995716 |
| 47 | MP0003448_altered_tumor_morphology | 1.34899224 |
| 48 | MP0000858_altered_metastatic_potential | 1.34174113 |
| 49 | MP0009840_abnormal_foam_cell | 1.32876407 |
| 50 | MP0002398_abnormal_bone_marrow | 1.29638662 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.28590829 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.28315949 |
| 53 | MP0001663_abnormal_digestive_system | 1.27935112 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.27459704 |
| 55 | MP0005164_abnormal_response_to | 1.23079724 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.22319941 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.20765266 |
| 58 | MP0000604_amyloidosis | 1.20343989 |
| 59 | MP0002332_abnormal_exercise_endurance | 1.16409644 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.14127126 |
| 61 | MP0003690_abnormal_glial_cell | 1.13380796 |
| 62 | MP0001853_heart_inflammation | 1.11162197 |
| 63 | MP0002429_abnormal_blood_cell | 1.09710019 |
| 64 | MP0004883_abnormal_blood_vessel | 1.05978023 |
| 65 | MP0002722_abnormal_immune_system | 1.05344462 |
| 66 | MP0005360_urolithiasis | 1.04647467 |
| 67 | MP0006054_spinal_hemorrhage | 1.03930850 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.03507569 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 0.99496074 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.98765827 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 0.97310668 |
| 72 | MP0001873_stomach_inflammation | 0.95642409 |
| 73 | MP0003828_pulmonary_edema | 0.95026580 |
| 74 | MP0009763_increased_sensitivity_to | 0.94988790 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.92491310 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.89928755 |
| 77 | MP0004858_abnormal_nervous_system | 0.89450018 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.85405753 |
| 79 | MP0005390_skeleton_phenotype | 0.84042603 |
| 80 | MP0000490_abnormal_crypts_of | 0.83677521 |
| 81 | MP0002006_tumorigenesis | 0.83513147 |
| 82 | MP0005381_digestive/alimentary_phenotyp | 0.83372097 |
| 83 | MP0002166_altered_tumor_susceptibility | 0.78566339 |
| 84 | MP0003329_amyloid_beta_deposits | 0.76892315 |
| 85 | MP0002132_abnormal_respiratory_system | 0.75945143 |
| 86 | MP0001501_abnormal_sleep_pattern | 0.75277470 |
| 87 | MP0005085_abnormal_gallbladder_physiolo | 0.75238614 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.74825186 |
| 89 | MP0000249_abnormal_blood_vessel | 0.74280633 |
| 90 | MP0001851_eye_inflammation | 0.70990371 |
| 91 | MP0005535_abnormal_body_temperature | 0.70144730 |
| 92 | MP0002254_reproductive_system_inflammat | 0.69787425 |
| 93 | MP0003091_abnormal_cell_migration | 0.69618518 |
| 94 | MP0008874_decreased_physiological_sensi | 0.68847940 |
| 95 | MP0003045_fibrosis | 0.67994851 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.67792401 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.65280400 |
| 98 | MP0003195_calcinosis | 0.64149292 |
| 99 | MP0000609_abnormal_liver_physiology | 0.60973012 |
| 100 | MP0000703_abnormal_thymus_morphology | 0.60458787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 6.04903546 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.89007563 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.87845651 |
| 4 | Optic neuritis (HP:0100653) | 5.87845651 |
| 5 | Myositis (HP:0100614) | 5.61053979 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.36709512 |
| 7 | Recurrent abscess formation (HP:0002722) | 5.11334183 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.06005492 |
| 9 | Stomatitis (HP:0010280) | 4.59274506 |
| 10 | Keratoconjunctivitis sicca (HP:0001097) | 4.25342344 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.15185808 |
| 12 | Keratoconjunctivitis (HP:0001096) | 3.90508366 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.89828505 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.89223049 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.82318114 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.74534782 |
| 17 | Vasculitis (HP:0002633) | 3.64098141 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.40286264 |
| 19 | Gingivitis (HP:0000230) | 3.37008298 |
| 20 | Encephalitis (HP:0002383) | 3.33355745 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.31140006 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.31140006 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.31140006 |
| 24 | Recurrent skin infections (HP:0001581) | 3.30793081 |
| 25 | Hemoptysis (HP:0002105) | 3.28207365 |
| 26 | Pulmonary infiltrates (HP:0002113) | 3.25108449 |
| 27 | Obstructive lung disease (HP:0006536) | 3.22443583 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22443583 |
| 29 | Meningitis (HP:0001287) | 3.20544202 |
| 30 | Increased IgM level (HP:0003496) | 3.16368337 |
| 31 | Malnutrition (HP:0004395) | 3.14557019 |
| 32 | Abnormality of T cell number (HP:0011839) | 3.12107062 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.06381492 |
| 34 | T lymphocytopenia (HP:0005403) | 3.05142442 |
| 35 | Arterial thrombosis (HP:0004420) | 3.02372401 |
| 36 | Amyloidosis (HP:0011034) | 3.00934677 |
| 37 | Gangrene (HP:0100758) | 2.98530472 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94989069 |
| 39 | Urticaria (HP:0001025) | 2.92041358 |
| 40 | Spontaneous hematomas (HP:0007420) | 2.89516955 |
| 41 | Loss of speech (HP:0002371) | 2.87728422 |
| 42 | Peritonitis (HP:0002586) | 2.82064399 |
| 43 | Leukocytosis (HP:0001974) | 2.76752449 |
| 44 | Anorexia (HP:0002039) | 2.73765546 |
| 45 | Disinhibition (HP:0000734) | 2.70731042 |
| 46 | Recurrent viral infections (HP:0004429) | 2.66355354 |
| 47 | Increased IgE level (HP:0003212) | 2.64644272 |
| 48 | Pulmonary embolism (HP:0002204) | 2.58025513 |
| 49 | Episodic fever (HP:0001954) | 2.57549551 |
| 50 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.54449779 |
| 51 | Chest pain (HP:0100749) | 2.54412498 |
| 52 | Abnormality of the pleura (HP:0002103) | 2.53356530 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53200638 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53200638 |
| 55 | Autoimmune hemolytic anemia (HP:0001890) | 2.46631049 |
| 56 | Gingival bleeding (HP:0000225) | 2.45319148 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.42212704 |
| 58 | Increased cerebral lipofuscin (HP:0011813) | 2.41106407 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.38491075 |
| 60 | Chronic diarrhea (HP:0002028) | 2.35115936 |
| 61 | Petechiae (HP:0000967) | 2.33343397 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.31084148 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.28925505 |
| 64 | Cellulitis (HP:0100658) | 2.28248493 |
| 65 | Hematochezia (HP:0002573) | 2.27441272 |
| 66 | Chronic otitis media (HP:0000389) | 2.24948754 |
| 67 | Glomerulonephritis (HP:0000099) | 2.21764615 |
| 68 | Joint swelling (HP:0001386) | 2.21627546 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.21201499 |
| 70 | Polyneuropathy (HP:0001271) | 2.20873478 |
| 71 | Acne (HP:0001061) | 2.18807632 |
| 72 | Vertigo (HP:0002321) | 2.17644185 |
| 73 | Abnormality of T cells (HP:0002843) | 2.15725828 |
| 74 | Glomerulopathy (HP:0100820) | 2.15437797 |
| 75 | Colitis (HP:0002583) | 2.14790559 |
| 76 | Eosinophilia (HP:0001880) | 2.10841309 |
| 77 | Abnormality of the endocardium (HP:0004306) | 2.10839307 |
| 78 | Abnormality of the pericardium (HP:0001697) | 2.10125474 |
| 79 | Granulocytopenia (HP:0001913) | 2.08695507 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.06270539 |
| 81 | Purpura (HP:0000979) | 2.05978796 |
| 82 | Increased serum ferritin (HP:0003281) | 2.05902480 |
| 83 | Premature loss of primary teeth (HP:0006323) | 2.05802219 |
| 84 | Recurrent bronchitis (HP:0002837) | 2.03833334 |
| 85 | Abnormality of the peritoneum (HP:0002585) | 2.03198034 |
| 86 | Osteomyelitis (HP:0002754) | 2.03044846 |
| 87 | Abnormality of B cell number (HP:0010975) | 2.01827978 |
| 88 | Epistaxis (HP:0000421) | 2.00969501 |
| 89 | Keratitis (HP:0000491) | 1.97264007 |
| 90 | Prolonged bleeding time (HP:0003010) | 1.97235170 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 1.96602852 |
| 92 | Arthralgia (HP:0002829) | 1.90617043 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 1.90078422 |
| 94 | Nasal polyposis (HP:0100582) | 1.87445233 |
| 95 | Pustule (HP:0200039) | 1.86762574 |
| 96 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.86048441 |
| 97 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.86026158 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85671300 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85389361 |
| 100 | Sepsis (HP:0100806) | 1.85066531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.08329913 |
| 2 | IRAK4 | 3.19454664 |
| 3 | TYK2 | 3.12632443 |
| 4 | BLK | 2.93695600 |
| 5 | ERN1 | 2.79076092 |
| 6 | MAP4K1 | 2.78122474 |
| 7 | IRAK3 | 2.76749031 |
| 8 | MAP3K14 | 2.70991537 |
| 9 | CSK | 2.59925577 |
| 10 | IKBKE | 2.40657203 |
| 11 | RIPK1 | 2.37389012 |
| 12 | MATK | 2.23998679 |
| 13 | TXK | 2.20227512 |
| 14 | TBK1 | 2.16474286 |
| 15 | JAK3 | 2.09457321 |
| 16 | MAP2K3 | 2.08765393 |
| 17 | FGR | 2.05222625 |
| 18 | ACVR1B | 1.98313004 |
| 19 | TAOK1 | 1.91970604 |
| 20 | PRPF4B | 1.86463694 |
| 21 | BMPR2 | 1.82534533 |
| 22 | GRK7 | 1.82107170 |
| 23 | IRAK1 | 1.79572715 |
| 24 | ZAP70 | 1.79039626 |
| 25 | EPHB1 | 1.76060220 |
| 26 | MAP3K11 | 1.63212383 |
| 27 | TAOK2 | 1.62380482 |
| 28 | JAK1 | 1.60960719 |
| 29 | MAP3K3 | 1.56341181 |
| 30 | IKBKB | 1.52634008 |
| 31 | JAK2 | 1.51695355 |
| 32 | FES | 1.44851606 |
| 33 | MAP3K1 | 1.43497743 |
| 34 | SYK | 1.39041461 |
| 35 | GRK6 | 1.38054928 |
| 36 | LYN | 1.37500893 |
| 37 | IRAK2 | 1.37374534 |
| 38 | EPHA3 | 1.28505455 |
| 39 | BTK | 1.27268740 |
| 40 | HCK | 1.21644385 |
| 41 | CDC42BPA | 1.17305451 |
| 42 | DDR2 | 1.17303315 |
| 43 | FGFR4 | 1.12748611 |
| 44 | TGFBR2 | 1.05516577 |
| 45 | MAP3K13 | 1.03277937 |
| 46 | TAOK3 | 0.99888485 |
| 47 | CSF1R | 0.99466280 |
| 48 | FGFR3 | 0.95334350 |
| 49 | LCK | 0.94732973 |
| 50 | TNK2 | 0.91223589 |
| 51 | KIT | 0.91055952 |
| 52 | MAP3K5 | 0.89429495 |
| 53 | KSR2 | 0.86730503 |
| 54 | YES1 | 0.82792756 |
| 55 | CHUK | 0.74784264 |
| 56 | MOS | 0.71482298 |
| 57 | MAP2K6 | 0.70500825 |
| 58 | SIK3 | 0.70110584 |
| 59 | TESK2 | 0.69536665 |
| 60 | PTK6 | 0.68329378 |
| 61 | MAP3K6 | 0.67585522 |
| 62 | PRKG2 | 0.66748252 |
| 63 | STK24 | 0.65918669 |
| 64 | MAP3K2 | 0.65053891 |
| 65 | PIM1 | 0.64720372 |
| 66 | PDK1 | 0.63713882 |
| 67 | ITK | 0.63087793 |
| 68 | MARK3 | 0.59826582 |
| 69 | PDPK1 | 0.57598753 |
| 70 | ADRBK2 | 0.57288961 |
| 71 | STK10 | 0.56770728 |
| 72 | NLK | 0.55287957 |
| 73 | TEC | 0.54489987 |
| 74 | FYN | 0.54380034 |
| 75 | DYRK1B | 0.53536193 |
| 76 | NME2 | 0.49231728 |
| 77 | DYRK3 | 0.48713972 |
| 78 | PIM2 | 0.48155481 |
| 79 | HIPK2 | 0.47631554 |
| 80 | MARK2 | 0.40302816 |
| 81 | DAPK2 | 0.39302080 |
| 82 | MAPK7 | 0.38116166 |
| 83 | LRRK2 | 0.36977489 |
| 84 | BMX | 0.35842597 |
| 85 | PIK3CA | 0.34371353 |
| 86 | MAPKAPK2 | 0.33595967 |
| 87 | CLK1 | 0.32387241 |
| 88 | MST1R | 0.32031705 |
| 89 | PRKCD | 0.28522070 |
| 90 | KSR1 | 0.27728661 |
| 91 | CDK6 | 0.26261985 |
| 92 | EGFR | 0.25837413 |
| 93 | RPS6KC1 | 0.25682557 |
| 94 | RPS6KL1 | 0.25682557 |
| 95 | SGK3 | 0.25646507 |
| 96 | PIK3CG | 0.25046880 |
| 97 | PRKCQ | 0.24798673 |
| 98 | PTK2B | 0.24736102 |
| 99 | PRKCZ | 0.23978649 |
| 100 | PRKAA2 | 0.23420768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.06557199 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86595602 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.74053063 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.65147569 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.60299271 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52546191 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22686311 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.21753853 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.21498782 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.21283294 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.18361302 |
| 12 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13119592 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.12655074 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04294984 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.98166171 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96942483 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.95334472 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89477340 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.89196402 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.88221378 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.80666800 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.80391010 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73923127 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.67054596 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63008347 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.61768368 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51844525 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48924111 |
| 29 | Salmonella infection_Homo sapiens_hsa05132 | 1.45676298 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44898612 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44310172 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41314574 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41064818 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39090788 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.38395493 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33893726 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32796429 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27846933 |
| 39 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23413022 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22634821 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.21175641 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.12697152 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08084067 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.04745239 |
| 45 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.01453760 |
| 46 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99176390 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.96681008 |
| 48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88201228 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87036103 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.84990032 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.84939528 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84315303 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83284580 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.81273939 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76090190 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75416841 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72636894 |
| 58 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72357597 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.71788168 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69714943 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69675126 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65450140 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59476387 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56279501 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55651355 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53916877 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.53642406 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51790350 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.51406348 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51086259 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48742299 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47368343 |
| 73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47269635 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47269091 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46472426 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46218798 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.45327836 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44470225 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43603563 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43152430 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42119914 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41543761 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41357138 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38853989 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38314602 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37274755 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36767317 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35895781 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.35274275 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.34853611 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33156924 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.32593522 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.32008009 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30580505 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30019673 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29222474 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28622740 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28398129 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27506288 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26593362 |

